[
  {
    "ts": null,
    "headline": "Zimmer Biomet Holdings Inc. stock outperforms competitors despite losses on the day",
    "summary": "Zimmer Biomet Holdings Inc. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=8b24a5cc22d2bdbd80a5fdf8045a4fd51ee52b01a4b1b629a68be77381dda955",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733332080,
      "headline": "Zimmer Biomet Holdings Inc. stock outperforms competitors despite losses on the day",
      "id": 131789020,
      "image": "",
      "related": "ZBH",
      "source": "MarketWatch",
      "summary": "Zimmer Biomet Holdings Inc. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=8b24a5cc22d2bdbd80a5fdf8045a4fd51ee52b01a4b1b629a68be77381dda955"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet Receives FDA Clearance for Persona® SoluTion™ PPS® Femur",
    "summary": "Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona® SoluTion™ Porous Plasma Spray (PPS®) Femur, a total knee implant component offering an alternative for patients with sensitivities to bone cement and/or metal. The Persona SoluTion PPS Femur features a porous coating for cementless fixation and leverages a proprietary surface treatment designed to enhance wear performance.1,2",
    "url": "https://finnhub.io/api/news?id=b510071b8ac3fecabdb1bec3bcfa8a4048b45569124aad7e333a38140bea6053",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733315400,
      "headline": "Zimmer Biomet Receives FDA Clearance for Persona® SoluTion™ PPS® Femur",
      "id": 131782122,
      "image": "https://media.zenfs.com/en/prnewswire.com/b2006881f7d00e48739c8660384a6286",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona® SoluTion™ Porous Plasma Spray (PPS®) Femur, a total knee implant component offering an alternative for patients with sensitivities to bone cement and/or metal. The Persona SoluTion PPS Femur features a porous coating for cementless fixation and leverages a proprietary surface treatment designed to enhance wear performance.1,2",
      "url": "https://finnhub.io/api/news?id=b510071b8ac3fecabdb1bec3bcfa8a4048b45569124aad7e333a38140bea6053"
    }
  }
]